319 related articles for article (PubMed ID: 28197963)
1. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Tsang M; Parikh SA
Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune cytopenias in chronic lymphocytic leukemia.
D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune cytopenias in chronic lymphocytic leukemia.
Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.
Osterborg A; Karlsson C; Lundin J
Curr Hematol Malig Rep; 2009 Jan; 4(1):47-53. PubMed ID: 20425438
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies.
Albiol N; Moreno C
Cancer J; 2021 Jul-Aug 01; 27(4):286-296. PubMed ID: 34398555
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
De Back TR; Kater AP; Tonino SH
Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
9. Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
Krečak I; Čengić M; Skorić I; Nakić M; Gverić-Krečak V
Ann Hematol; 2021 Nov; 100(11):2861-2862. PubMed ID: 34109444
[No Abstract] [Full Text] [Related]
10. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V
Leukemia; 2023 Jul; 37(7):1464-1473. PubMed ID: 37202442
[TBL] [Abstract][Full Text] [Related]
11. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
13. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.
Zent CS; Ding W; Reinalda MS; Schwager SM; Hoyer JD; Bowen DA; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Kay NE; Slager SL
Leuk Lymphoma; 2009 Aug; 50(8):1261-8. PubMed ID: 19811329
[TBL] [Abstract][Full Text] [Related]
15. Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL.
Hochman MJ; Martin DB
Ann Hematol; 2021 Feb; 100(2):579-580. PubMed ID: 32548659
[No Abstract] [Full Text] [Related]
16. Chronic lymphocytic leukemia-associated pure red cell aplasia.
D'Arena G; Cascavilla N
Int J Immunopathol Pharmacol; 2009; 22(2):279-86. PubMed ID: 19505381
[TBL] [Abstract][Full Text] [Related]
17. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy.
Molica S; Polliack A
Leuk Res; 2016 Nov; 50():31-36. PubMed ID: 27657651
[TBL] [Abstract][Full Text] [Related]
19. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
20. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
